Oncology – Latest Research – LinksMedicus @oncology_linksmedicus Channel on Telegram

Oncology – Latest Research – LinksMedicus

@oncology_linksmedicus


Oncology - Content Curation & Alerts in Medicine

Website:
https://www.linksmedicus.com/
Support our work:
https://www.buymeacoffee.com/LinksMedicus

Oncology – Latest Research – LinksMedicus (English)

Are you a healthcare professional looking to stay up-to-date with the latest research and developments in the field of oncology? Look no further than the Oncology – Latest Research – LinksMedicus Telegram channel! This channel, with the username @oncology_linksmedicus, is your go-to source for curated content and alerts in medicine, specifically focusing on oncology. LinksMedicus is a well-known platform that provides valuable insights and resources for healthcare professionals worldwide. With a dedicated focus on oncology, this channel offers a one-stop solution for staying informed about the most recent advancements in the field. From clinical trials to treatment options, you can find a wide range of information that is relevant to your practice. The channel not only shares the latest research articles and studies but also provides links to reputable sources, ensuring that you have access to accurate and reliable information. Whether you are a physician, researcher, nurse, or student, Oncology – Latest Research – LinksMedicus has something to offer to everyone interested in the field of oncology. To make things even better, LinksMedicus has a website that serves as an additional resource for those looking to delve deeper into the world of oncology. You can visit their website at https://www.linksmedicus.com/ to explore more content and stay updated on the latest trends in medicine. As a healthcare professional, it is essential to stay informed about the latest research and developments in your field. By joining the Oncology – Latest Research – LinksMedicus Telegram channel, you can ensure that you are always ahead of the curve and equipped with the knowledge needed to provide the best care for your patients. Support the valuable work of LinksMedicus by visiting https://www.buymeacoffee.com/LinksMedicus and contributing to their mission of spreading knowledge and awareness in the field of oncology. Together, we can make a difference in the lives of those affected by cancer. Don't miss out on this opportunity to join a community of like-minded professionals who are passionate about oncology. Stay informed, stay connected, and stay ahead with Oncology – Latest Research – LinksMedicus!

Oncology – Latest Research – LinksMedicus

02 Apr, 10:39


📣 Explore IntelliDoctor’s New Free Voice Recognition Feature -

https://www.linksmedicus.com/news/explore-intellidoctors-new-free-voice-recognition-feature/

Oncology – Latest Research – LinksMedicus

04 Mar, 10:52


📣 Access IntelliDoctor for Free: Answers to all medical questions with our AI-based platform -

https://www.linksmedicus.com/news/access-intellidoctor-for-free-answers-to-all-medical-questions-with-our-ai-based-platform/

Oncology – Latest Research – LinksMedicus

26 Feb, 11:23


📣 Introducing IntelliDoctor: The Future of Medical Inquiry for Medical Professionals -

https://www.linksmedicus.com/news/introducing-intellidoctor-the-future-of-medical-inquiry-for-medical-professionals/

Oncology – Latest Research – LinksMedicus

18 Dec, 10:50


📣 AI-Powered GPTs for Doctors: Evidence-Based Medicine & Clinical Decision Support Prompts - IntelliDoctor

https://www.linksmedicus.com/news/ai-powered-gpts-for-doctors-evidence-based-medicine-clinical-decision-support-prompts/

Oncology – Latest Research – LinksMedicus

23 Aug, 12:53


📣 LinksMedicus.com: operations paused for the foreseeable future. - LinksMedicus

https://www.linksmedicus.com/news/linksmedicus-com-operations-paused-for-the-foreseeable-future/

Oncology – Latest Research – LinksMedicus

11 Aug, 15:25


📣 RCT | Superior PFS with avelumab vs. chemotherapy in second-line treatment for mCRC with microsatellite instability - JAMA Oncol

https://www.linksmedicus.com/news/rct-superior-pfs-avelumab-vs-chemotherapy-second-line-treatment-mcrc-microsatellite-instability/

Oncology – Latest Research – LinksMedicus

11 Aug, 15:17


📣 RCT – 2ry analysis | Aerobic exercise intervention shows potential to reduce chemotherapy-induced peripheral neuropathy - JAMA Netw Open

https://www.linksmedicus.com/news/rct-2ry-analysis-aerobic-exercise-intervention-shows-potential-reduce-chemotherapy-induced-peripheral-neuropathy/

Oncology – Latest Research – LinksMedicus

09 Aug, 15:28


📣 Phase 2 RCT | Adding stereotactic body radiotherapy to immune checkpoint inhibitors fails to improve outcomes in solid tumor patients - JAMA Oncol

https://www.linksmedicus.com/news/phase-2-rct-adding-stereotactic-body-radiotherapy-immune-checkpoint-inhibitors-fails-improve-outcomes-solid-tumor-patients/

Oncology – Latest Research – LinksMedicus

09 Aug, 15:27


📣 Cohort Study | Moderate to heavy drinking linked to increased risk of early-onset colorectal cancer - J Clin Oncol

https://www.linksmedicus.com/news/cohort-study-moderate-heavy-drinking-linked-increased-risk-early-onset-colorectal-cancer/

Oncology – Latest Research – LinksMedicus

08 Aug, 13:22


📣 Determination of “borderline resectable” pancreatic cancer – A global assessment of 30 shades of grey - HPB

https://www.linksmedicus.com/news/determination-borderline-resectable-pancreatic-cancer-global-assessment-30-shades-grey/

Oncology – Latest Research – LinksMedicus

08 Aug, 13:11


📣 Systematic Review | Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer - Cochrane Library

https://www.linksmedicus.com/news/systematic-review-pegylated-liposomal-doxorubicin-relapsed-epithelial-ovarian-cancer/

Oncology – Latest Research – LinksMedicus

08 Aug, 13:07


📣 Cohort Study | Potential negative survival impact of PPI and palbociclib co-administration in breast cancer patients - JAMA Netw Open

https://www.linksmedicus.com/news/cohort-study-potential-negative-survival-impact-ppi-palbociclib-co-administration-breast-cancer-patients/

Oncology – Latest Research – LinksMedicus

07 Aug, 14:40


📣 RCT | Upfront radiosurgery reduces tumor volume vs. a wait-and-scan approach in small- to medium-sized vestibular schwannoma - JAMA

https://www.linksmedicus.com/news/rct-upfront-radiosurgery-reduces-tumor-volume-vs-wait-scan-approach-small-medium-sized-vestibular-schwannoma/

Oncology – Latest Research – LinksMedicus

07 Aug, 14:38


📣 RCT | Zolbetuximab plus CAPOX as potential first-line treatment for CLDN18.2+, HER2- advanced gastric adenocarcinoma - Nature Med

https://www.linksmedicus.com/news/rct-zolbetuximab-plus-capox-potential-first-line-treatment-cldn18-2-her2-advanced-gastric-adenocarcinoma/

Oncology – Latest Research – LinksMedicus

04 Aug, 12:14


📣 RCT | Mammography screening with AI reduces workload by 44.3% without loss in detection efficacy - Lancet Oncol

https://www.linksmedicus.com/news/rct-mammography-screening-ai-reduces-workload-44-3-without-loss-detection-efficacy/

Oncology – Latest Research – LinksMedicus

04 Aug, 12:09


📣 Study | Removal of thymus in adults linked to increased death, cancer incidence - N Engl J Med

https://www.linksmedicus.com/news/study-removal-thymus-adults-linked-increased-death-cancer-incidence/

Oncology – Latest Research – LinksMedicus

04 Aug, 12:05


📣 NICE Updated Guideline | Diagnosis and management of lung cancer - National Institute for Health and Care Excellence

https://www.linksmedicus.com/news/nice-updated-guideline-diagnosis-management-lung-cancer/

Oncology – Latest Research – LinksMedicus

04 Aug, 12:03


📣 ASCO Guideline Update | Management of Stage III Non–Small-Cell Lung Cancer - J Clin Oncol

https://www.linksmedicus.com/news/asco-guideline-update-management-stage-iii-non-small-cell-lung-cancer/

Oncology – Latest Research – LinksMedicus

03 Aug, 13:48


📣 ACP Guidance | Asymptomatic CRC screening advised from age 50 with fecal occult blood test every 2 years or colonoscopy every 10 years - Ann Intern Med

https://www.linksmedicus.com/news/acp-guidance-asymptomatic-crc-screening-advised-age-50-fecal-occult-blood-test-every-2-years-colonoscopy-every-10-years/

Oncology – Latest Research – LinksMedicus

03 Aug, 13:36


📣 Systematic Review | Interstitial lung disease incidence at 11.7% in metastatic breast cancer patients using trastuzumab deruxtecan - ESMO Open

https://www.linksmedicus.com/news/systematic-review-interstitial-lung-disease-incidence-11-7-metastatic-breast-cancer-patients-using-trastuzumab-deruxtecan/